Advance care planning in older patients with acute myeloid leukemia and myelodysplastic syndromes
- PMID: 36100548
- PMCID: PMC9974785
- DOI: 10.1016/j.jgo.2022.09.003
Advance care planning in older patients with acute myeloid leukemia and myelodysplastic syndromes
Abstract
Introduction: Older patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) have worse survival rates compared to younger patients, and experience more intense inpatient healthcare at the end of life (EOL) compared to patients with solid tumors. Advance care planning (ACP) has been shown to limit aggressive and burdensome care at EOL for patients with AML and MDS. The purpose of this study was to better understand ACP from the perspective of clinicians, older patients with AML and MDS, and their caregivers.
Materials and methods: We conducted semi-structured interviews with 45 study participants. Interviews were audio-recorded and transcribed. Open coding and focused content analysis were used to organize data and develop and contextualize categories and subcategories.
Results: Guided by our specific aims, we developed four themes: (1) The language of ACP and medical order for life-sustaining treatment (MOLST) does not resonate with patients, (2) There is no uniform consensus on when ACP is currently happening, (3) Oncology clinician-perceived barriers to ACP (e.g., patient discomfort, patient lack of knowledge, and lack of time), and (4) Patients felt that they are balancing fear and hope when navigating their AML or MDS diagnosis.
Discussion: The results of this study can be used to develop interventions to promote serious illness conversations for patients with AML and MDS and their caregivers to ensure that patient care aligns with patient values.
Keywords: Acute myeloid leukemia; Advance care planning; Hematologic malignancy; Myelodysplastic syndromes; Qualitative study.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest Dr. Loh has served as a consultant to Pfizer and Seattle Genetics and has received honoraria from Pfizer.
Similar articles
-
Adaptation of Serious Illness Care Program to be delivered via telehealth for older patients with hematologic malignancy.Blood Adv. 2023 May 9;7(9):1871-1884. doi: 10.1182/bloodadvances.2022008996. Blood Adv. 2023. PMID: 36521100 Free PMC article.
-
Portable Medical Orders and Inpatient Cost at End of Life in Acute Myeloid Leukemia and Myelodysplastic Syndromes.JCO Oncol Pract. 2025 Jun;21(6):876-882. doi: 10.1200/OP-24-00556. Epub 2024 Dec 16. JCO Oncol Pract. 2025. PMID: 39680824
-
Using Social Media to Uncover Treatment Experiences and Decisions in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Who Are Ineligible for Intensive Chemotherapy: Patient-Centric Qualitative Data Analysis.J Med Internet Res. 2019 Nov 22;21(11):e14285. doi: 10.2196/14285. J Med Internet Res. 2019. PMID: 31755871 Free PMC article.
-
Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis.Eur J Haematol. 2020 May;104(5):476-487. doi: 10.1111/ejh.13389. Epub 2020 Mar 3. Eur J Haematol. 2020. PMID: 31985078 Free PMC article. Review.
-
Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly.Clin Geriatr Med. 2016 Feb;32(1):155-73. doi: 10.1016/j.cger.2015.08.010. Clin Geriatr Med. 2016. PMID: 26614866 Free PMC article. Review.
Cited by
-
Adaptation of Serious Illness Care Program to be delivered via telehealth for older patients with hematologic malignancy.Blood Adv. 2023 May 9;7(9):1871-1884. doi: 10.1182/bloodadvances.2022008996. Blood Adv. 2023. PMID: 36521100 Free PMC article.
-
Clinicians' Perspectives on the Telehealth Serious Illness Care Program for Older Adults With Myeloid Malignancies: Single-Arm Pilot Study.JMIR Form Res. 2024 Jun 27;8:e58503. doi: 10.2196/58503. JMIR Form Res. 2024. PMID: 38935428 Free PMC article.
-
Perspectives of Patients With Relapsed and Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome on Patient-Clinician Communication About Prognosis and the Future.Palliat Med Rep. 2024 Jan 19;5(1):53-62. doi: 10.1089/pmr.2023.0064. eCollection 2024. Palliat Med Rep. 2024. PMID: 38249836 Free PMC article.
-
Barriers and facilitators that hospital clinicians perceive to discuss the personal values, wishes, and needs of patients in palliative care: a mixed-methods systematic review.Palliat Care Soc Pract. 2023 Dec 1;17:26323524231212510. doi: 10.1177/26323524231212510. eCollection 2023. Palliat Care Soc Pract. 2023. PMID: 38044932 Free PMC article. Review.
References
-
- Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges. Blood Rev 2019;36:70–87. - PubMed
-
- Zeidan AM, Shallis RM, Wang R, Davidoff A, Ma X. Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it. Blood Rev 2019;34:1–15. - PubMed
-
- Lerch E, Espeli V, Zucca E, Leoncini L, Scali G, Mora O, et al. Prognosis of acute myeloid leukemia in the general population: data from southern Switzerland. Tumori 2009;95(3):303–10. - PubMed
-
- Alibhai SM, Leach M, Minden MD, Brandwein J. Outcomes and quality of care in acute myeloid leukemia over 40 years. Cancer 2009;115(13):2903–11. - PubMed
-
- Verhoef MJ, de Nijs EJM, Ootjers CS, Fiocco M, Fogteloo AJ, Heringhaus C, et al. End-of-Life Trajectories of Patients With Hematological Malignancies and Patients With Advanced Solid Tumors Visiting the Emergency Department: The Need for a Proactive Integrated Care Approach. Am J Hosp Palliat Care 2020;37(9):692–700. - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous